Results 41 to 50 of about 17,377 (218)

ATTR Gene Variants in HCM

open access: yesJACC: Case Reports
Hypertrophic cardiomyopathy is the most common inherited cardiomyopathy, with a prevalence of 1:200 to 1:500. Cardiac amyloidosis, another cardiomyopathy caused by myocardial deposition of abnormally folded TTR protein, can be acquired or hereditary. The presence of pathogenic TTR gene variants in patients with phenotypic HCM is an underrecognized and ...
Kanelidis, Anthony J.   +6 more
openaire   +4 more sources

Baseline characteristics of patients with ATTR cardiac amyloidosis.

open access: yes, 2021
Data are presented as percentages, as appropriate. Abbreviations: ATTR, transthyretin amyloidosis. (DOCX)
Zaza Iakobishvili (505022)   +6 more
core   +1 more source

Cryo-EM structure of an ATTRwt amyloid fibril from systemic non-hereditary transthyretin amyloidosis

open access: yesNature Communications, 2022
This manuscript reports the structure of a pathologically relevant wild type ATTR amyloid fibril from systemic non-hereditary transthyretin amyloidosis.
Maximilian Steinebrei   +6 more
doaj   +1 more source

Structural basis for transthyretin amyloid formation in vitreous body of the eye

open access: yesNature Communications, 2021
Systemic ATTR amyloidosis causes the abnormal accumulation of ATTR fibrils formed from the human plasma protein transthyretin (TTR) in multiple organs including the eye.
Irina Iakovleva   +5 more
doaj   +1 more source

Progression and prognostic significance of electrocardiographic findings in patients with cardiac amyloidosis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 809-818, April 2025.
Abstract Aims This study aimed to evaluate the change of the main electrocardiographic (ECG) characteristics and their prognostic role across the main subtypes of cardiac amyloidosis [light‐chain amyloidosis (AL) and hereditary (ATTRv) and wild‐type transthyretin amyloidosis (ATTRwt)].
Alessia Argirò   +20 more
wiley   +1 more source

Val122Ile mt-ATTR Has a Worse Survival Than wt-ATTR Cardiac Amyloidosis

open access: yesJournal of the American College of Cardiology, 2017
Maurer et al. [(1)][1] reported results from the THAOS (Transthyretin Amyloid Outcome Survey) registry of transthyretin cardiac amyloid (ATTR) amyloidosis, in which they compared differences between patients carrying wild-type ATTR (wt-ATTR) cardiac amyloidosis and those carrying the mutant ...
Avinainder, Singh   +2 more
openaire   +2 more sources

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya   +9 more
wiley   +1 more source

ATTR Variant Amyloidosis in Patients with Dysphagia

open access: yes, 2023
Amyloidosis is a rare disease characterized by the accumulation of misfolded extracellular proteins in various organs. Over 30 precursor proteins have been identified that can form amyloid deposits in different parts of the body.
Christina Hui Lee Ng   +2 more
core   +1 more source

Prevalence of transthyretin cardiac amyloidosis in undifferentiated heart failure with preserved ejection fraction

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1176-1182, April 2025.
Abstract Aims Transthyretin amyloid cardiomyopathy (ATTR‐CM) is an increasinglyrecognized cause of heart failure with preserved ejection fraction (HFpEF), which may be diagnosed non‐invasively using 99mTc 3,3‐diphosphono‐1,2‐propanodicarboxylic acid (DPD) scintigraphy‐based diagnostic criteria.
L. Healy   +15 more
wiley   +1 more source

Prevalence, incidence and clinical outcomes of epicardial coronary artery disease among transthyretin amyloidosis cardiomyopathy patients

open access: yesBMC Cardiovascular Disorders, 2023
Background Transthyretin amyloidosis cardiomyopathy (ATTR-CM) patients are often older and may be at risk for obstructive epicardial coronary artery disease (oeCAD).
Rana Hassan   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy